Global Niraparib Market Growth 2025-2031

December 2025 | 78 pages | ID: G713CBF417CEN
LP Information

Abstracts

The global Niraparib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Niraparib is a medication that is used to treat some types of cancer, such as ovarian, fallopian tube, or primary peritoneal cancer. It belongs to a class of drugs called PARP inhibitors, which block an enzyme that helps repair damaged DNA in cancer cells. By preventing DNA repair, niraparib can cause cancer cells to die or stop growing. Niraparib is taken by mouth as a capsule, usually once a day.

The future market trends of niraparib are expected to be positive, as the demand for this product is driven by the increasing prevalence of cancer and the need for effective and personalized treatment options. Niraparib has shown promising results in improving the survival and quality of life of patients with different types of cancer, especially those with BRCA mutations or homologous recombination deficiency (HRD). Niraparib is also being investigated for other indications, such as prostate, breast, and pancreatic cancer, as well as in combination with other therapies, such as immunotherapy or chemotherapy.

LP Information, Inc. (LPI) ' newest research report, the “Niraparib Industry Forecast” looks at past sales and reviews total world Niraparib sales in 2024, providing a comprehensive analysis by region and market sector of projected Niraparib sales for 2025 through 2031. With Niraparib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Niraparib industry.

This Insight Report provides a comprehensive analysis of the global Niraparib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Niraparib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Niraparib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Niraparib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Niraparib.

This report presents a comprehensive overview, market shares, and growth opportunities of Niraparib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 100mg*30 Capsules
• 100mg*60 Capsules
• 100mg*90 Capsules

Segmentation by Application:

• Recurrent Epithelial Ovarian Cancer
• Fallopian Tube Cancer
• Primary Peritoneal Cancer
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• TESARO
• Everest Pharmaceuticals Limited

Key Questions Addressed in this Report

What is the 10-year outlook for the global Niraparib market?

What factors are driving Niraparib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Niraparib market opportunities vary by end market size?

How does Niraparib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Niraparib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Niraparib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Niraparib by Country/Region, 2020, 2024 & 2031
2.2 Niraparib Segment by Type
  2.2.1 100mg*30 Capsules
  2.2.2 100mg*60 Capsules
  2.2.3 100mg*90 Capsules
2.3 Niraparib Sales by Type
  2.3.1 Global Niraparib Sales Market Share by Type (2020-2025)
  2.3.2 Global Niraparib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Niraparib Sale Price by Type (2020-2025)
2.4 Niraparib Segment by Application
  2.4.1 Recurrent Epithelial Ovarian Cancer
  2.4.2 Fallopian Tube Cancer
  2.4.3 Primary Peritoneal Cancer
  2.4.4 Others
2.5 Niraparib Sales by Application
  2.5.1 Global Niraparib Sale Market Share by Application (2020-2025)
  2.5.2 Global Niraparib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Niraparib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Niraparib Breakdown Data by Company
  3.1.1 Global Niraparib Annual Sales by Company (2020-2025)
  3.1.2 Global Niraparib Sales Market Share by Company (2020-2025)
3.2 Global Niraparib Annual Revenue by Company (2020-2025)
  3.2.1 Global Niraparib Revenue by Company (2020-2025)
  3.2.2 Global Niraparib Revenue Market Share by Company (2020-2025)
3.3 Global Niraparib Sale Price by Company
3.4 Key Manufacturers Niraparib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Niraparib Product Location Distribution
  3.4.2 Players Niraparib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NIRAPARIB BY GEOGRAPHIC REGION

4.1 World Historic Niraparib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Niraparib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Niraparib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Niraparib Market Size by Country/Region (2020-2025)
  4.2.1 Global Niraparib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Niraparib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Niraparib Sales Growth
4.4 APAC Niraparib Sales Growth
4.5 Europe Niraparib Sales Growth
4.6 Middle East & Africa Niraparib Sales Growth

5 AMERICAS

5.1 Americas Niraparib Sales by Country
  5.1.1 Americas Niraparib Sales by Country (2020-2025)
  5.1.2 Americas Niraparib Revenue by Country (2020-2025)
5.2 Americas Niraparib Sales by Type (2020-2025)
5.3 Americas Niraparib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Niraparib Sales by Region
  6.1.1 APAC Niraparib Sales by Region (2020-2025)
  6.1.2 APAC Niraparib Revenue by Region (2020-2025)
6.2 APAC Niraparib Sales by Type (2020-2025)
6.3 APAC Niraparib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Niraparib by Country
  7.1.1 Europe Niraparib Sales by Country (2020-2025)
  7.1.2 Europe Niraparib Revenue by Country (2020-2025)
7.2 Europe Niraparib Sales by Type (2020-2025)
7.3 Europe Niraparib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Niraparib by Country
  8.1.1 Middle East & Africa Niraparib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Niraparib Revenue by Country (2020-2025)
8.2 Middle East & Africa Niraparib Sales by Type (2020-2025)
8.3 Middle East & Africa Niraparib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Niraparib
10.3 Manufacturing Process Analysis of Niraparib
10.4 Industry Chain Structure of Niraparib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Niraparib Distributors
11.3 Niraparib Customer

12 WORLD FORECAST REVIEW FOR NIRAPARIB BY GEOGRAPHIC REGION

12.1 Global Niraparib Market Size Forecast by Region
  12.1.1 Global Niraparib Forecast by Region (2026-2031)
  12.1.2 Global Niraparib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Niraparib Forecast by Type (2026-2031)
12.7 Global Niraparib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 TESARO
  13.1.1 TESARO Company Information
  13.1.2 TESARO Niraparib Product Portfolios and Specifications
  13.1.3 TESARO Niraparib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 TESARO Main Business Overview
  13.1.5 TESARO Latest Developments
13.2 Everest Pharmaceuticals Limited
  13.2.1 Everest Pharmaceuticals Limited Company Information
  13.2.2 Everest Pharmaceuticals Limited Niraparib Product Portfolios and Specifications
  13.2.3 Everest Pharmaceuticals Limited Niraparib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Everest Pharmaceuticals Limited Main Business Overview
  13.2.5 Everest Pharmaceuticals Limited Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Niraparib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Niraparib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg*30 Capsules
Table 4. Major Players of 100mg*60 Capsules
Table 5. Major Players of 100mg*90 Capsules
Table 6. Global Niraparib Sales by Type (2020-2025) & (K Pcs)
Table 7. Global Niraparib Sales Market Share by Type (2020-2025)
Table 8. Global Niraparib Revenue by Type (2020-2025) & ($ million)
Table 9. Global Niraparib Revenue Market Share by Type (2020-2025)
Table 10. Global Niraparib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global Niraparib Sale by Application (2020-2025) & (K Pcs)
Table 12. Global Niraparib Sale Market Share by Application (2020-2025)
Table 13. Global Niraparib Revenue by Application (2020-2025) & ($ million)
Table 14. Global Niraparib Revenue Market Share by Application (2020-2025)
Table 15. Global Niraparib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global Niraparib Sales by Company (2020-2025) & (K Pcs)
Table 17. Global Niraparib Sales Market Share by Company (2020-2025)
Table 18. Global Niraparib Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Niraparib Revenue Market Share by Company (2020-2025)
Table 20. Global Niraparib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers Niraparib Producing Area Distribution and Sales Area
Table 22. Players Niraparib Products Offered
Table 23. Niraparib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Niraparib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global Niraparib Sales Market Share Geographic Region (2020-2025)
Table 28. Global Niraparib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Niraparib Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Niraparib Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global Niraparib Sales Market Share by Country/Region (2020-2025)
Table 32. Global Niraparib Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Niraparib Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Niraparib Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas Niraparib Sales Market Share by Country (2020-2025)
Table 36. Americas Niraparib Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Niraparib Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas Niraparib Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC Niraparib Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC Niraparib Sales Market Share by Region (2020-2025)
Table 41. APAC Niraparib Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Niraparib Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC Niraparib Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe Niraparib Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe Niraparib Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Niraparib Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe Niraparib Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Niraparib Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa Niraparib Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Niraparib Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa Niraparib Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of Niraparib
Table 53. Key Market Challenges & Risks of Niraparib
Table 54. Key Industry Trends of Niraparib
Table 55. Niraparib Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Niraparib Distributors List
Table 58. Niraparib Customer List
Table 59. Global Niraparib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global Niraparib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Niraparib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas Niraparib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Niraparib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC Niraparib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Niraparib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe Niraparib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Niraparib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa Niraparib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Niraparib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global Niraparib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Niraparib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global Niraparib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. TESARO Basic Information, Niraparib Manufacturing Base, Sales Area and Its Competitors
Table 74. TESARO Niraparib Product Portfolios and Specifications
Table 75. TESARO Niraparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. TESARO Main Business
Table 77. TESARO Latest Developments
Table 78. Everest Pharmaceuticals Limited Basic Information, Niraparib Manufacturing Base, Sales Area and Its Competitors
Table 79. Everest Pharmaceuticals Limited Niraparib Product Portfolios and Specifications
Table 80. Everest Pharmaceuticals Limited Niraparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Everest Pharmaceuticals Limited Main Business
Table 82. Everest Pharmaceuticals Limited Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Niraparib
Figure 2. Niraparib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Niraparib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Niraparib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Niraparib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Niraparib Sales Market Share by Country/Region (2024)
Figure 10. Niraparib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg*30 Capsules
Figure 12. Product Picture of 100mg*60 Capsules
Figure 13. Product Picture of 100mg*90 Capsules
Figure 14. Global Niraparib Sales Market Share by Type in 2025
Figure 15. Global Niraparib Revenue Market Share by Type (2020-2025)
Figure 16. Niraparib Consumed in Recurrent Epithelial Ovarian Cancer
Figure 17. Global Niraparib Market: Recurrent Epithelial Ovarian Cancer (2020-2025) & (K Pcs)
Figure 18. Niraparib Consumed in Fallopian Tube Cancer
Figure 19. Global Niraparib Market: Fallopian Tube Cancer (2020-2025) & (K Pcs)
Figure 20. Niraparib Consumed in Primary Peritoneal Cancer
Figure 21. Global Niraparib Market: Primary Peritoneal Cancer (2020-2025) & (K Pcs)
Figure 22. Niraparib Consumed in Others
Figure 23. Global Niraparib Market: Others (2020-2025) & (K Pcs)
Figure 24. Global Niraparib Sale Market Share by Application (2024)
Figure 25. Global Niraparib Revenue Market Share by Application in 2025
Figure 26. Niraparib Sales by Company in 2025 (K Pcs)
Figure 27. Global Niraparib Sales Market Share by Company in 2025
Figure 28. Niraparib Revenue by Company in 2025 ($ millions)
Figure 29. Global Niraparib Revenue Market Share by Company in 2025
Figure 30. Global Niraparib Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global Niraparib Revenue Market Share by Geographic Region in 2025
Figure 32. Americas Niraparib Sales 2020-2025 (K Pcs)
Figure 33. Americas Niraparib Revenue 2020-2025 ($ millions)
Figure 34. APAC Niraparib Sales 2020-2025 (K Pcs)
Figure 35. APAC Niraparib Revenue 2020-2025 ($ millions)
Figure 36. Europe Niraparib Sales 2020-2025 (K Pcs)
Figure 37. Europe Niraparib Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa Niraparib Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa Niraparib Revenue 2020-2025 ($ millions)
Figure 40. Americas Niraparib Sales Market Share by Country in 2025
Figure 41. Americas Niraparib Revenue Market Share by Country (2020-2025)
Figure 42. Americas Niraparib Sales Market Share by Type (2020-2025)
Figure 43. Americas Niraparib Sales Market Share by Application (2020-2025)
Figure 44. United States Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC Niraparib Sales Market Share by Region in 2025
Figure 49. APAC Niraparib Revenue Market Share by Region (2020-2025)
Figure 50. APAC Niraparib Sales Market Share by Type (2020-2025)
Figure 51. APAC Niraparib Sales Market Share by Application (2020-2025)
Figure 52. China Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 56. India Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe Niraparib Sales Market Share by Country in 2025
Figure 60. Europe Niraparib Revenue Market Share by Country (2020-2025)
Figure 61. Europe Niraparib Sales Market Share by Type (2020-2025)
Figure 62. Europe Niraparib Sales Market Share by Application (2020-2025)
Figure 63. Germany Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 64. France Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 65. UK Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa Niraparib Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa Niraparib Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa Niraparib Sales Market Share by Application (2020-2025)
Figure 71. Egypt Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries Niraparib Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Niraparib in 2025
Figure 77. Manufacturing Process Analysis of Niraparib
Figure 78. Industry Chain Structure of Niraparib
Figure 79. Channels of Distribution
Figure 80. Global Niraparib Sales Market Forecast by Region (2026-2031)
Figure 81. Global Niraparib Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global Niraparib Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global Niraparib Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global Niraparib Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global Niraparib Revenue Market Share Forecast by Application (2026-2031)